Cheap Drug Could Cut 10% Off UK Breast Cancer Deaths, Charity Says…
While we can all appreciate the constant advancement of cancer research findings and treatment over time, it is no secret that anti-cancer drug expenses have been sky-rocketing simultaneously. The UK’s biggest breast cancer charity, Breast Cancer Now, however, may be on the right track to discovering an alternative, more cost friendly drug for breast cancer survivors.
The charity claims that bisphosphonates, a cheap drug typically used to strengthen the bones of women diagnosed with osteoporosis could potentially prevent breast cancer from returning. If offered to more women, this drug which cost around 43p a day may be the answer to saving more women’s lives.
After a review in 2015 showed that bisphosphonates could also reduce the number of breast cancers in postmenopausal women from 8.8% to 6.6%, the charity estimates that if the drug were given routinely to all eligible women in the UK, an extra 1,180 death each year could be prevented, which is the equivalent of one in 10 breast cancer deaths’.
While NICE and the NHS still appear to be a bit sceptical about differentiating between which groups of postmenopausal women will benefit from this treatment, the charity says, doctors on the UK Breast Cancer Group and NHS England’s Breast Cancer Clinical Expert Group support the use of bisphosphonates.
In fact, Delyth Morgan, chief executive of the charity, said: “In bisphosphonates, we have a simple and cost-effective chance to cut 10% of all UK breast cancer deaths, using drugs already at the NHS’s disposal. That this is not being taken is nothing short of a dereliction of duty”.
For more information, click here.